TRIM13抗体—艾普蒂

+ +

•  

   

     The image is immunohistochemistry of paraffin-embedded Human ovarian cancer tissue using P08477(TRIM13 Antibody) at dilution 1/30. (Original magnification: ×200)    

  
  

**Background of TRIM13 Antibody**

TRIM13 (Tripartite Motif-containing protein 13) is a member of the TRIM family, characterized by conserved RING, B-box, and coiled-coil domains. It localizes primarily to the endoplasmic reticulum (ER) and plays roles in ER-associated degradation (ERAD), ubiquitination, apoptosis, and immune regulation. TRIM13 functions as an E3 ubiquitin ligase, mediating protein ubiquitination to regulate cellular processes like protein quality control and stress responses. Its involvement in pathways such as NF-κB signaling and p53-mediated apoptosis highlights its dual role in tumor suppression and oncogenesis, depending on cellular context.

TRIM13 antibodies are essential tools for studying its expression, localization, and function in physiological and pathological conditions. These antibodies enable detection via techniques like Western blotting, immunohistochemistry (IHC), and immunofluorescence (IF). Research using TRIM13 antibodies has linked its dysregulation to cancers (e.g., multiple myeloma, leukemia), neurodegenerative diseases, and viral infections, underscoring its therapeutic potential. Additionally, studies explore TRIM13's interaction with viral proteins and its role in modulating autophagy and ER stress.

Validated TRIM13 antibodies are critical for ensuring specificity, particularly given structural similarities among TRIM family members. Ongoing research aims to clarify its mechanistic roles and explore TRIM13 as a biomarker or therapeutic target in disease.